Location History:
- Ellicott, MD (US) (1987)
- Ellicott City, MD (US) (1988)
- Ellicot City, MD (US) (2008)
Company Filing History:
Years Active: 1987-2008
Title: Innovations and Contributions of John J Sauk
Introduction
John J Sauk is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of therapeutic agents and compositions for osseous repair. With a total of 3 patents, his work has had a meaningful impact on medical science.
Latest Patents
One of his latest patents is titled "Surface localized colligin/Hsp47 in carcinoma cells." This invention relates to colligin/Hsp47 molecules that are expressed on the surface of carcinoma cells. It explores the use of these expressed molecules as targets for therapeutic or imaging agents. Additionally, it includes peptides that specifically bind to the external domains of these surface-localized Hsp47 molecules. Another significant patent is "Physically stable composition and method of use thereof for osseous." This invention describes a composition for osseous repair, which is prepared by mixing a particulate polycrystalline calcium phosphate ceramic, a phosphophoryn calcium salt, and type I collagen. The resulting solid porous composition is effective in promoting new bone formation when introduced into osseous defects.
Career Highlights
Throughout his career, John J Sauk has worked with esteemed organizations such as the University System of Maryland and Minnesota Mining and Manufacturing Company. His experience in these institutions has allowed him to develop innovative solutions in his field.
Collaborations
John has collaborated with various professionals, including Craig L Van Kampen, to further enhance his research and inventions.
Conclusion
John J Sauk's contributions to the field of biomedical engineering through his patents and collaborations highlight his dedication to innovation and improving medical treatments. His work continues to influence the development of new therapeutic agents and compositions for osseous repair.